Tue, October 1, 2024
[ 12:00 AM ] - WOPRAI
Tue, August 20, 2024
Mon, August 19, 2024
Tue, August 13, 2024
[ 12:00 AM ] - WOPRAI
Mon, May 13, 2024
[ 12:00 AM ] - WOPRAI
Fri, May 3, 2024
[ 12:00 AM ] - WOPRAI
Thu, May 2, 2024
[ 12:00 AM ] - WOPRAI
Thu, March 7, 2024
[ 12:00 AM ] - WOPRAI
Thu, February 29, 2024
[ 12:00 AM ] - WOPRAI
Thu, February 22, 2024
Tue, November 7, 2023
Tue, October 3, 2023
[ 12:00 AM ] - WOPRAI
Fri, September 1, 2023
[ 12:00 AM ] - WOPRAI
Thu, August 31, 2023
[ 12:00 AM ] - WOPRAI
Fri, August 18, 2023
[ 12:00 AM ] - WOPRAI
Thu, May 18, 2023
[ 12:00 AM ] - WOPRAI
Tue, May 9, 2023
[ 12:00 AM ] - WOPRAI
Tue, February 14, 2023
[ 12:00 AM ] - WOPRAI
Fri, February 3, 2023
[ 12:00 AM ] - WOPRAI
Tue, December 21, 2021
[ 12:00 AM ] - WOPRAI
Fri, July 16, 2021
[ 12:00 AM ] - WOPRAI
Tue, May 25, 2021
[ 12:00 AM ] - WOPRAI
Fri, May 14, 2021
Tue, March 23, 2021
[ 12:00 AM ] - WOPRAI
Tue, August 11, 2020
Thu, May 14, 2020
[ 12:00 AM ] - WOPRAI
Wed, February 19, 2020
Robert Wasserman Reiterated (ANEB) at Buy and Held Target at $8 on, Oct 1st, 2024
Robert Wasserman of Benchmark, Reiterated "Anebulo Pharmaceuticals, Inc." (ANEB) at Buy and Held Target at $8 on, Oct 1st, 2024.
Robert, nor any peers, have made any analyst calls on ANEB in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources